Regeneron Pharmaceuticals Inc (REGN)

Days of sales outstanding (DSO)

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Receivables turnover		2.29	2.30	2.27	2.65	2.71
DSO	days	159.65	158.58	160.56	137.58	134.56

December 31, 2024 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 2.29
= 159.65

Regeneron Pharmaceuticals Inc's Days of Sales Outstanding (DSO) has shown a gradual increase over the past five years. The company's DSO was 134.56 days as of December 31, 2020, and has steadily climbed to 159.65 days as of December 31, 2024. This trend indicates that Regeneron Pharmaceuticals is taking longer to collect its accounts receivable, which could potentially impact its cash flow and liquidity position. It is essential for the company to closely monitor and manage its DSO to ensure efficient credit management and timely collection of sales proceeds.